World / Gastroenterology
Patient Enrollment For AspenBio Pharma's FDA 510(k) Clinical Trial For AppyScore(TM), World's First Appendicitis Blood Test, Nearing Halfway Point
05.09.2008 18:15
medicalnewstoday.com
AspenBio Pharma, Inc. (NASDAQ: APPY) an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for humans and animals, reported enrollment levels are approaching fifty percent in the ongoing FDA 510(k) clinical trial for AppyScore(TM), the world's first blood-based diagnostic tool for human appendicitis.
World
Gastroenterology
Alte Biosciences Files Patent For New Inflammatory Bowel Disease Drugs - Unique Compositions Of Matter To Treat Gastrointestinal Disorders
05.09.2008 06:17
medicalnewstoday.com
Alte Bioscience, Inc., a development stage pharmaceutical company, is pleased to announce the filing of a provisional patent for a new class of drugs that may benefit patients with inflammatory bowel disease. This is the latest in a series of pharmaceutical inventions held by Alte Biosciences, adding to its portfolio of patents of drugs for the treatment of late onset depression and innovative systems for drug delivery, packaging, and manufacturing.
World
Gastroenterology
English